Your browser doesn't support javascript.
COVID-19 in vaccinated versus unvaccinated hematologic malignancy patients.
DeVoe, Catherine; Pandey, Shraddha; Shariff, Dayana; Arora, Shagun; Henrich, Timothy J; Yokoe, Deborah S; Langelier, Charles R; Servellita, Venice; Chiu, Charles; Miller, Steve; Babik, Jennifer M; Chin-Hong, Peter; Fung, Monica.
  • DeVoe C; Division of Infectious Diseases, Department of Medicine, University of California San Francisco, San Francisco, California, USA.
  • Pandey S; Division of Infectious Diseases, Department of Medicine, University of California San Francisco, San Francisco, California, USA.
  • Shariff D; Division of Infectious Diseases, Department of Medicine, University of California San Francisco, San Francisco, California, USA.
  • Arora S; Division of Hematology/Oncology, Department of Medicine, University of California San Francisco, San Francisco, California, USA.
  • Henrich TJ; Division of Infectious Diseases, Department of Medicine, University of California San Francisco, San Francisco, California, USA.
  • Yokoe DS; Division of Experimental Medicine, University of California San Francisco, San Francisco, California, USA.
  • Langelier CR; Division of Infectious Diseases, Department of Medicine, University of California San Francisco, San Francisco, California, USA.
  • Servellita V; Division of Infectious Diseases, Department of Medicine, University of California San Francisco, San Francisco, California, USA.
  • Chiu C; Chan Zuckerberg Biohub, San Francisco, California, USA.
  • Miller S; Department of Laboratory Medicine, University of California San Francisco, San Francisco, California, USA.
  • Babik JM; Division of Infectious Diseases, Department of Medicine, University of California San Francisco, San Francisco, California, USA.
  • Chin-Hong P; Department of Laboratory Medicine, University of California San Francisco, San Francisco, California, USA.
  • Fung M; Department of Laboratory Medicine, University of California San Francisco, San Francisco, California, USA.
Transpl Infect Dis ; : e13835, 2022 Apr 15.
Article in English | MEDLINE | ID: covidwho-2229451
ABSTRACT
The effect of vaccination on severity of subsequent COVID-19 in patients with hematologic malignancies (HMs) is unknown. In this single-center retrospective cohort study, we found no difference in severity of COVID-19 disease in vaccinated (n = 16) versus unvaccinated (n = 54) HM patients using an adjusted multiple logistic regression model. Recent anti-B-cell therapy was associated with more severe illness.
Keywords
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Type of study: Cohort study / Observational study / Prognostic study Topics: Vaccines Language: English Journal: Transpl Infect Dis Journal subject: Transplantation Year: 2022 Document Type: Article Affiliation country: Tid.13835

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Type of study: Cohort study / Observational study / Prognostic study Topics: Vaccines Language: English Journal: Transpl Infect Dis Journal subject: Transplantation Year: 2022 Document Type: Article Affiliation country: Tid.13835